IHS Holding Ltd. IHS 深 滬
等待開盤 04-22 09:30:00 美东时间
8.25
0.000
0.00%
華盛通- 最 高8.26
- 今 開8.25
- 成交量 74.46万股
- 最 低 8.24
- 昨 收 8.25
- 總市值 27.72亿
- 52周最高 8.95
- 市盈率 靜 19.63
- 換手率 0.22%
- 52周最低 4.87
- 委 比 84.69%
- 總股本 3.36亿
- 歷史最高 18.48
- 量 比 1.36
- 振 幅 0.24%
- 歷史最低 2.18
- 每 手 1
- 風險率 0.97%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅216.49%！杰富瑞上调BioAge Labs目标价至62美元，评级升至"买入"
今日重点评级关注：杰富瑞：上调BioAge Labs评级至"买入"，目标价从9美元升至62美元；RBC Capital：维持COMPASS Pathways Plc Sponsored ADR"跑赢大市"评级，目标价从21美元升至22美元
02-19 16:21
TD Cowen Downgrades IHS Holding to Hold, Lowers Price Target to $8.5
TD Cowen analyst Michael Elias downgrades IHS Holding (NYSE:IHS) from Buy to Hold and lowers the price target from $17 to $8.5.
02-19 02:49
IHS Mauritius BR Agrees To Sell Latin America Tower Operations To Macquarie Asset Management For ~$952M
IHS Mauritius BR Limited, part of IHS Holding Limited (NYSE: IHS) ("IHS Towers" or the "Company"), one of the largest independent owners, operators and developers of shared communications infrastructure in the world by
02-17 21:48
IHS Towers Confirms That Discussions Are Ongoing With MTN Regarding A Potential Acquisition By MTN Of All Remaining Shares It Does Not Already Own In IHS Towers
IHS Holding Limited, (NYSE:IHS) ("IHS Towers" or the "Company"), one of the largest independent owners, operators and developers of shared communications infrastructure in the world by tower count, today issues the
02-05 23:28
JPMorgan’s top short ideas for Q1: FTNT, TXT, IMO and more
J.P. Morgan’s U.S. equity thematic research team surveyed its top-ranked analysts to identify their most compelling structural and tactical short ideas heading into the first quarter of 2026. They fea...
01-24 00:24
Best performing integrated telecom stocks YTD as group posts impressive gains
The integrated telecommunication services sector has delivered impressive returns for investors in 2025, with several stocks posting triple-digit gains. The following screen identifies the top perform...
2025-12-30 01:31
美股大行评级 | 摩根大通上调百度至"超配"，目标价升至188美元！Navan获多家机构首予"买入"评级，目标价最高30美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从4美元升至9美元；BTIG：维持Cullinan Therapeutics"买入"评级，目标价从32美元升至38美元
2025-11-25 10:27
Citigroup Maintains Buy on IHS Holding, Raises Price Target to $9
Citigroup analyst Michael Rollins maintains IHS Holding (NYSE:IHS) with a Buy and raises the price target from $8.75 to $9.
2025-11-25 02:41
美股大行评级 | 高盛上调百度、美敦力、晶科能源等多只个股目标价；家得宝遭9家机构下调目标价；
今日重点评级关注：富国银行：维持Annexon"超配"评级，目标价从14美元升至27美元；瑞穗：上调Relmada Therapeutics评级至"跑赢大市"，目标价从1美元升至10美元
2025-11-20 10:28
美股大行评级 | 花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级
花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>
2025-11-17 10:49
